Information intended for UK healthcare professionals and other relevant decision makers only. Adverse event reporting can be found at the bottom of the page.
Click here for prescribing information. This website is owned and fully funded by Alliance Pharmaceuticals.

FAQs

Forceval® Capsules

While most patients can meet nutritional needs through a balanced diet, there are some clinical circumstances where supplements can provide additional nutritional support that might otherwise be lacking.  Research shows that a multivitamin and mineral medicine might help some patients e.g. those with diagnosed deficiencies, malabsorption, post-surgical nutritional needs and chronic conditions affecting nutrient intake or absorption.

Forceval® Capsules are not suitable for vegetarians/ vegans as the capsules contain gelatine that is derived from bovine sources.

Forceval® Capsules may be administered during pregnancy and lactation at the recommendation of a doctor.

For the most up to date information please contact medical information by email on medinfo@alliancepharma.co.uk

For the most up to date information please contact medical information by email on medinfo@alliancepharma.co.uk

There are 2500 International Units (IU) of vitamin A (as beta carotene), or 750 mcg retinol equivalents.1
There are 400 International Units (IU) of vitamin D2 in Forceval® Capsules which is equivalent to 10mcg.1
All Forceval® products are reimbursable on prescription.
Forceval® Capsules is recommended for children over the age of 12, adults and the elderly.
Forceval® Capsules should be taken once per day, swallowed whole with water and preferably taken one hour after meals. The stated dose should not be exceeded.
  1. Forceval® Capsules Patient Informtion Leaflet. Available at: https://www.medicines.org.uk​/emc/files/pil.3911.pdf
References accessed February 2026.

Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk or by searching for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Pharmacovigilance at Alliance Pharmaceuticals Ltd, Tel: 01249 466966, email: pharmacovigilance@alliancepharma.co.uk.

Please consult the Summary of Product Characteristics for a full listing of contraindications, precautions, and adverse events before prescribing this medicine. Rash, nausea, vomiting and abdominal pain have been reported (frequency not known). Should not be given to individuals with allergies to peanut or soya, hypercalcaemia, haemochromatosis, other iron storage disorders, hypersensitivity to the active substance(s) or to any of the excipients.